Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2003
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
08/06/2003EP1331933A2 The use of tiagabine for treatment of diabetic neuropathy and migraine
08/06/2003EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators
08/06/2003EP1331930A2 Methods and compositions for regulating memory consolidation
08/06/2003EP1331855A2 Aged companion pet diet
08/06/2003EP1244498B1 Combination of trimebutine with an opioid analgesic
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1126846B1 Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP1066027B1 Pharmaceutical composition of topiramate
08/06/2003EP0980381B1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
08/06/2003EP0946538B1 Indane or dihydroindole derivatives
08/06/2003EP0880358B1 Inhibitors of cyclophilin rotamase activity
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434724A Remedies and/or preventives for nervous system disorders
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434715A Pharmaceutical compositions
08/06/2003CN1434714A Method and composition for the treatment of pain
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434708A Novel sertraline hydrochl oride polymorphs, processes for preparing them, compositions containing them and methods of using them
08/06/2003CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose
08/06/2003CN1433809A Medicine for treating gynecopathy and preparation process thereof
08/06/2003CN1433798A Medine for dispelling alcohol effect and making method thereof
08/06/2003CN1433762A New use of fluoroquinolone group medicine and berberine
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1116880C Use of puffer liver oil in preparing food for curing poisonous drug dependence
08/06/2003CN1116870C Applicatino of preventing and treating peripheral neurophathy by administering selegiline
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603011 3-pyridinyl compounds
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6602911 Methods of treating fibromyalgia
08/05/2003US6602903 Substituted heterocyclic compounds
08/05/2003US6602891 Muscarinic receptor agonists
08/05/2003US6602889 5-heteroaryl substituted indoles
08/05/2003US6602887 Chronic, bolus administration of D-threo methylphenidate
08/05/2003US6602886 3-alkyl-3-phenyl-piperidines
08/05/2003US6602885 Viricides, organ transplants, antiarthritic agents
08/05/2003US6602881 Anti-inflammatory uses of manzamines
08/05/2003US6602874 5-(2-(4-methylpiperazin-1-yl)-phenyl)- furan-2-carboxylic acid 4-chlorobenzylamide, for example; treating or preventing migraine, depression and other disorders for which a 5-HT1, agonist or antagonist is indicated
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
08/05/2003US6602868 Administering a heterocyclic amine or a phenylazacycloalkane
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602865 Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003CA2419989A1 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
08/05/2003CA2329259C Convection-enhanced delivery of aav vectors
08/05/2003CA2088798C Condensed imidazopyridine derivatives
08/05/2003CA2087672C 1,5-benzodiazepine derivatives
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
07/2003
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062440A1 Xanthone derivative
07/31/2003WO2003062405A2 Method for inducing differentiation of embryonic stem cells
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062252A1 Edg receptor agonists
07/31/2003WO2003062245A1 Fused bicyclic pyrimidine derivatives
07/31/2003WO2003062243A1 Novel compounds as semaphorin inhibitors
07/31/2003WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
07/31/2003WO2003062240A1 Pteridine derivatives, method for the production thereof, and use thereof
07/31/2003WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
07/31/2003WO2003062232A1 Derivatives of thiazoles used for the treatment of neurological diseases
07/31/2003WO2003062227A1 Rho-kinase inhibitors
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 1833